Influencing Factors for Physical Activity in People With Head and Neck Cancer (ProAct-HNC)

August 28, 2025 updated by: Kantonsspital Winterthur KSW

Exploring Influencing Factors for Physical Activity Participation in People With Advanced Head and Neck Cancer - a Qualitative Study

The goal of this qualitative study is to explore influencing factors for physical activity (PA) participation in people affected by an advanced head and neck cancer from the perspective of people affected and their significant others.

Individual interviews will be conducted with people affected by head and neck cancer and focus group interviews will be held with significant others of people being affected to answer the following research questions:

  • What capabilities and opportunities for physical activity participation do people with advanced head and neck cancer experience?
  • What motivates people with advanced head and neck cancer to be physically active?
  • What are recommendations and suggestions for a future physical activity promotion intervention?
  • How do significant others view capabilities, opportunities, and motivation for physical activity participation and promotion in people with head and neck cancer?

The interviews will be transcribed verbatim and analysed with a structuring content analysis approach.

Study Overview

Detailed Description

see attached study protocol

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Canton of Zurich
      • Winterthur, Canton of Zurich, Switzerland
        • Kantonsspital Winterthur

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

individual interview participants: 12 individuals with a diagnosis of a stage III or IV head and neck squamous cell carcinoma, after surgery & (chemo)radiotherapy

focus group interview participants: 8 significant others (partner, spouse, close familiy member or friend) of individuals with a diagnosis of a stage III or IV head and neck squamous cell carcinoma

Description

Inclusion criteria for people with head and neck cancer:

  • minimal age 18
  • diagnosis of a primary head and neck squamous cell carcinoma within the last 24 months
  • oral, pharyngeal, or laryngeal cancer stage III or IV
  • completed surgery and/or radio(chemo)therapy in curative intent

Exclusion criteria for people with head and neck cancer:

  • not having the physical, mental, and cognitive ability to understand, follow and hold a conversation in (Swiss-)German
  • treatment in palliative intent
  • recurrence of the head and neck tumour (local or distant)

Inclusion criteria for significant others of people with head and neck cancer:

  • minimal age 18
  • being a significant other (partner, spouse, close family member or friend) of an individual with a head and neck cancer with the above-mentioned criteria
  • having the permission of the individual affected by head and neck cancer to talk about their experiences

Exclusion criteria for significant others of people with head and neck cancer:

- not having the physical, mental, and cognitive ability to understand, follow and take part in a group discussion in (Swiss-)German

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
interview transcripts
Time Frame: March 2024- May 2025
individual interviews and focus group interviews will be transcribed verbatim to be analyzed
March 2024- May 2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
personal information of participants
Time Frame: March 2024- May 2025
characteristics of interview and focus group participants will be collected to be able to describe the study participants, including age, education level, cancer stage, treatment received, activity levels
March 2024- May 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2024

Primary Completion (Actual)

July 30, 2025

Study Completion (Actual)

July 30, 2025

Study Registration Dates

First Submitted

February 15, 2024

First Submitted That Met QC Criteria

February 15, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Estimated)

August 29, 2025

Last Update Submitted That Met QC Criteria

August 28, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ProAct-HNC-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Head and Neck Squamous Cell Carcinoma

Subscribe